{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:38Z","timestamp":1793413958795,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s40801-019-00161-y","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:02:51Z","timestamp":1565334171000},"page":"141-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System"],"prefix":"10.1007","volume":"6","author":[{"given":"Matthew S.","family":"Duprey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada S.","family":"Al-Qadheeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith B.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Madias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Dimbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1751-9012","authenticated-orcid":false,"given":"John W.","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"issue":"12","key":"161_CR1","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1097\/CCM.0b013e3181b02eff","volume":"37","author":"H Wunsch","year":"2009","unstructured":"Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD. Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med. 2009;37(12):3031\u20139.","journal-title":"Crit Care Med."},{"issue":"11 Suppl. 3","key":"161_CR2","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.joms.2012.07.030","volume":"70","author":"PG Sims","year":"2012","unstructured":"Sims PG, Kates CH, Moyer DJ, Rollert MK, Todd DW. Anesthesia in outpatient facilities. J Oral Maxillofac Surg. 2012;70(11 Suppl. 3):e31\u201349.","journal-title":"J Oral Maxillofac Surg."},{"issue":"11","key":"161_CR3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jama.2012.270","volume":"307","author":"H Liu","year":"2012","unstructured":"Liu H, Waxman DA, Main R, Mattke S. Utilization of anesthesia services during outpatient endoscopies and colonoscopies and associated spending in 2003\u20132009. JAMA. 2012;307(11):1178\u201384.","journal-title":"JAMA."},{"issue":"1","key":"161_CR4","first-page":"18","volume":"13","author":"H Toman","year":"2016","unstructured":"Toman H, Erkilinc A, Kocak T, et al. Sedation for transesophageal echocardiography: comparison of propofol, midazolam and midazolam\u2013alfentanil combination. Med Glas (Zenica). 2016;13(1):18\u201324.","journal-title":"Med Glas (Zenica)."},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/BCR.0000000000000423","volume":"38","author":"R Myers","year":"2017","unstructured":"Myers R, Lozenski J, Wyatt M, et al. Sedation and analgesia for dressing change: a survey of American Burn Association burn centers. J Burn Care Res. 2017;38:e48\u201354.","journal-title":"J Burn Care Res"},{"issue":"10","key":"161_CR6","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1592\/phco.2005.25.10.1319","volume":"25","author":"R MacLaren","year":"2005","unstructured":"MacLaren R, Sullivan PW. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients. Pharmacotherapy. 2005;25(10):1319\u201328.","journal-title":"Pharmacotherapy."},{"issue":"1","key":"161_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"J Barr","year":"2013","unstructured":"Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263\u2013306.","journal-title":"Crit Care Med."},{"issue":"6 Suppl.","key":"161_CR8","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1097\/CCM.0b013e3181de125a","volume":"38","author":"JW Devlin","year":"2010","unstructured":"Devlin JW, Mallow-Corbett S, Riker RR. Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med. 2010;38(6 Suppl.):S231\u201343.","journal-title":"Crit Care Med."},{"issue":"5 Pt 2","key":"161_CR9","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1592\/phco.2005.25.5_Part_2.8S","volume":"25","author":"RR Riker","year":"2005","unstructured":"Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy. 2005;25(5 Pt 2):8S\u201318S.","journal-title":"Pharmacotherapy."},{"issue":"6","key":"161_CR10","first-page":"325","volume":"71","author":"C Melloni","year":"2005","unstructured":"Melloni C. Morbidity and mortality related to anesthesia outside the operating room. Minerva Anestesiol. 2005;71(6):325\u201334.","journal-title":"Minerva Anestesiol."},{"issue":"2","key":"161_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/acem.12875","volume":"23","author":"MF Bellolio","year":"2016","unstructured":"Bellolio MF, Gilani WI, Barrionuevo P, et al. Incidence of adverse events in adults undergoing procedural sedation in the emergency department: a systematic review and meta-analysis. Acad Emerg Med. 2016;23(2):119\u201334.","journal-title":"Acad Emerg Med."},{"issue":"40","key":"161_CR12","doi-asserted-by":"publisher","first-page":"e1459","DOI":"10.1097\/MD.0000000000001459","volume":"94","author":"KS Hong","year":"2015","unstructured":"Hong KS, Choi EY, Park DA, Park J. Safety and efficacy of the moderate sedation during flexible bronchoscopic procedure: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2015;94(40):e1459.","journal-title":"Medicine (Baltimore)."},{"issue":"4","key":"161_CR13","first-page":"505","volume":"21","author":"Y Guo","year":"2012","unstructured":"Guo Y, Zhang H, Feng X, Wang A. A retrospective study of risk factors for cardiopulmonary events during propofol-mediated gastrointestinal endoscopy in patients aged over 70 years. Middle East J Anaesthesiol. 2012;21(4):505\u201311.","journal-title":"Middle East J Anaesthesiol."},{"issue":"4 Suppl.","key":"161_CR14","first-page":"S21","volume":"77","author":"CC Hug Jr","year":"1993","unstructured":"Hug CC Jr, McLeskey CH, Nahrwold ML, et al. Hemodynamic effects of propofol: data from over 25,000 patients. Anesth Analg. 1993;77(4 Suppl.):S21\u20139.","journal-title":"Anesth Analg."},{"issue":"4","key":"161_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/01.pap.0000249925.76324.47","volume":"16","author":"J Darrouj","year":"2009","unstructured":"Darrouj J, Karma L, Arora R. Cardiovascular manifestations of sedatives and analgesics in the critical care unit. Am J Ther. 2009;16(4):339\u201353.","journal-title":"Am J Ther."},{"key":"161_CR16","unstructured":"Ativan (lorazepam) injection [package insert]. Eatontown (NJ): West-Ward Pharmaceuticals Corp; 2017. https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=5fc0e987-61c9-40c4-b0d5-fcea07c8733e&type=pdf&name=5fc0e987-61c9-40c4-b0d5-fcea07c8733e . Accessed 09 May 2019."},{"key":"161_CR17","unstructured":"Midazolam injection [package insert]. Lake Forest (IL): Akorn, Inc; 2016. https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=737361a0-8db1-4d3c-ba5e-44df3f49fa22&type=pdf&name=737361a0-8db1-4d3c-ba5e-44df3f49fa22 . Accessed 09 May 2019."},{"key":"161_CR18","unstructured":"Precedex (dexmedetomidine) injection [package insert]. Lake Forest (IL): Hospira Inc; 2016. https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=548a88c0-afda-427e-75ac-5af0cfa2224c&type=pdf&name=548a88c0-afda-427e-75ac-5af0cfa2224c . Accessed 09 May 2019."},{"key":"161_CR19","unstructured":"Diazepam injection [package insert]. Lake Forest (IL): Hospira Inc; 2016. https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=41044928-dd1f-40bf-1fa6-709dff559124&type=pdf&name=41044928-dd1f-40bf-1fa6-709dff559124 . Accessed 09 May 2019."},{"key":"161_CR20","unstructured":"Diprivan (propofol) injection [package insert]. Lake Zurich (IL): Fresenius Kabi USA LLC; 2014. https:\/\/dailymed.nlm.nih.gov\/dailymed\/getFile.cfm?setid=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538&type=pdf&name=e3105799-a4b6-f3f4-e6e2-b2b29bbdb538 . Accessed 09 May 2019."},{"issue":"5","key":"161_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2009.56","volume":"301","author":"RR Riker","year":"2009","unstructured":"Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489\u201399.","journal-title":"JAMA."},{"issue":"22","key":"161_CR22","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","volume":"298","author":"PP Pandharipande","year":"2007","unstructured":"Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644\u201353.","journal-title":"JAMA."},{"issue":"11","key":"161_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.2012.304","volume":"307","author":"SM Jakob","year":"2012","unstructured":"Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151\u201360.","journal-title":"JAMA."},{"issue":"2","key":"161_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1378\/chest.103.2.557","volume":"103","author":"G Carrasco","year":"1993","unstructured":"Carrasco G, Molina R, Costa J, Soler JM, Cabre L. Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients :a cost-benefit analysis. Chest. 1993;103(2):557\u201364.","journal-title":"Chest."},{"issue":"6","key":"161_CR25","first-page":"1219","volume":"86","author":"JA Sanchez-Izquierdo-Riera","year":"1998","unstructured":"Sanchez-Izquierdo-Riera JA, Caballero-Cubedo RE, Perez-Vela JL, Ambros-Checa A, Cantalapiedra-Santiago JA, Alted-Lopez E. Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg. 1998;86(6):1219\u201324.","journal-title":"Anesth Analg."},{"issue":"6","key":"161_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0016-5107(99)70281-6","volume":"49","author":"T Wehrmann","year":"1999","unstructured":"Wehrmann T, Kokabpick S, Lembcke B, Caspary WF, Seifert H. Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. Gastrointest Endosc. 1999;49(6):677\u201383.","journal-title":"Gastrointest Endosc."},{"issue":"7\u20138","key":"161_CR27","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1345\/aph.1D615","volume":"38","author":"JF Dasta","year":"2004","unstructured":"Dasta JF, Kane-Gill SL, Durtschi AJ. Comparing dexmedetomidine prescribing patterns and safety in the naturalistic setting versus published data. Ann Pharmacother. 2004;38(7\u20138):1130\u20135.","journal-title":"Ann Pharmacother."},{"issue":"2","key":"161_CR28","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/cc8956","volume":"14","author":"DL Jackson","year":"2010","unstructured":"Jackson DL, Proudfoot CW, Cann KF, Walsh T. A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care. 2010;14(2):R59.","journal-title":"Crit Care."},{"issue":"3","key":"161_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2344\/0003-3006-58.3.126","volume":"58","author":"DE Becker","year":"2011","unstructured":"Becker DE, Haas DA. Recognition and management of complications during moderate and deep sedation. Part 2: cardiovascular considerations. Anesth Prog. 2011;58(3):126\u201338.","journal-title":"Anesth Prog"},{"issue":"2","key":"161_CR30","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/ALN.0b013e31827773e9","volume":"118","author":"JL Apfelbaum","year":"2013","unstructured":"Apfelbaum JL, Silverstein JH, Chung FF, et al. Practice guidelines for postanesthetic care: an updated report by the American Society of Anesthesiologists Task Force on Postanesthetic Care. Anesthesiology. 2013;118(2):291\u2013307.","journal-title":"Anesthesiology."},{"issue":"6","key":"161_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s40264-016-0409-x","volume":"39","author":"KB Hoffman","year":"2016","unstructured":"Hoffman KB, Dimbil M, Tatonetti NP, Kyle RF. A pharmacovigilance signaling system based on FDA regulatory action and post-marketing adverse event reports. Drug Saf. 2016;39(6):561\u201375.","journal-title":"Drug Saf."},{"issue":"8","key":"161_CR32","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1097\/CCM.0b013e318180c1eb","volume":"36","author":"JJ Fong","year":"2008","unstructured":"Fong JJ, Sylvia L, Ruthazer R, Schumaker G, Kcomt M, Devlin JW. Predictors of mortality in patients with suspected propofol infusion syndrome. Crit Care Med. 2008;36(8):2281\u20137.","journal-title":"Crit Care Med."},{"issue":"9","key":"161_CR33","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1592\/phco.24.13.1122.38098","volume":"24","author":"M Hauben","year":"2004","unstructured":"Hauben M. Application of an empiric Bayesian data mining algorithm to reports of pancreatitis associated with atypical antipsychotics. Pharmacotherapy. 2004;24(9):1122\u20139.","journal-title":"Pharmacotherapy."},{"issue":"1","key":"161_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4081\/dts.2013.e4","volume":"3","author":"KB Hoffman","year":"2013","unstructured":"Hoffman KB, Overstreet BM, Doraiswamy PM. Development of a drug safety ePlatform for physicians, pharmacists, and consumers based on post-marketing adverse events. Drugs Ther Stud. 2013;3(1):4.","journal-title":"Drugs Ther Stud."},{"issue":"8","key":"161_CR35","doi-asserted-by":"publisher","first-page":"e42866","DOI":"10.1371\/journal.pone.0042866","volume":"7","author":"KB Hoffman","year":"2012","unstructured":"Hoffman KB, Kraus C, Dimbil M, Golomb BA. A survey of the FDA\u2019s AERS database regarding muscle and tendon adverse events linked to the statin drug class. PLoS One. 2012;7(8):e42866.","journal-title":"PLoS One."},{"key":"161_CR36","doi-asserted-by":"publisher","first-page":"f4656","DOI":"10.1136\/bmj.f4656","volume":"347","author":"KB Hoffman","year":"2013","unstructured":"Hoffman KB, Demakas A, Erdman CB, Dimbil M, Doraiswamy PM. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999\u20132012. BMJ. 2013;347:f4656.","journal-title":"BMJ."},{"issue":"12","key":"161_CR37","first-page":"1134","volume":"21","author":"KB Hoffman","year":"2015","unstructured":"Hoffman KB, Dimbil M, Kyle RF, et al. A drug safety rating system based on postmarketing costs associated with adverse events and patient outcomes. J Manag Care Spec Pharm. 2015;21(12):1134\u201343.","journal-title":"J Manag Care Spec Pharm."},{"key":"161_CR38","unstructured":"Medical Dictionary for Regulatory Activities. Standardised MedDRA queries. 2014. www.meddra.org\/standardised-meddra-queries . Accessed 09 May 2019."},{"issue":"4","key":"161_CR39","first-page":"e290","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics: 2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e290\u2013322.","journal-title":"Circulation."},{"issue":"11","key":"161_CR40","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1097\/CCM.0b013e3182257459","volume":"39","author":"RM Merchant","year":"2011","unstructured":"Merchant RM, Yang L, Becker LB, et al. Incidence of treated cardiac arrest in hospitalized patients in the United States. Crit Care Med. 2011;39(11):2401\u20136.","journal-title":"Crit Care Med."},{"issue":"1","key":"161_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5049\/EBP.2011.9.1.27","volume":"9","author":"JH Lee","year":"2011","unstructured":"Lee JH, Ko YS, Shin HJ, Yi JH, Han SW, Kim HJ. Is there a relationship between hyperkalemia and propofol? Electrolyte Blood Press. 2011;9(1):27\u201331.","journal-title":"Electrolyte Blood Press."},{"issue":"6","key":"161_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00132580-200211000-00004","volume":"4","author":"EA Bermudez","year":"2002","unstructured":"Bermudez EA, Chen MH. Cardiac arrest associated with intravenous propofol during transesophageal echocardiography before DC cardioversion. Heart Dis. 2002;4(6):355\u20137.","journal-title":"Heart Dis."},{"issue":"4","key":"161_CR43","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.aat.2011.11.010","volume":"49","author":"S Bharati","year":"2011","unstructured":"Bharati S, Pal A, Biswas C, Biswas R. Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan. 2011;49(4):165\u20137.","journal-title":"Acta Anaesthesiol Taiwan."},{"issue":"12","key":"161_CR44","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1345\/aph.1M313","volume":"43","author":"EL Horinek","year":"2009","unstructured":"Horinek EL, Kiser TH, Fish DN, MacLaren R. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother. 2009;43(12):1964\u201371.","journal-title":"Ann Pharmacother."},{"issue":"8","key":"161_CR45","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1097\/01.CCM.0000134831.40466.39","volume":"32","author":"AC Arroliga","year":"2004","unstructured":"Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med. 2004;32(8):1709\u201314.","journal-title":"Crit Care Med."},{"issue":"9","key":"161_CR46","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1177\/000992287501400910","volume":"14","author":"R Berger","year":"1975","unstructured":"Berger R, Green G, Melnick A. Cardiac arrest caused by oral diazepam intoxication. Clin Pediatr (Phila). 1975;14(9):842\u20134.","journal-title":"Clin Pediatr (Phila)."},{"issue":"2","key":"161_CR47","first-page":"86","volume":"33","author":"PM Sherman","year":"1975","unstructured":"Sherman PM. Letter: further comments on cardiac arrest from diazepam. J Oral Surg. 1975;33(2):86.","journal-title":"J Oral Surg."},{"issue":"9","key":"161_CR48","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.resuscitation.2013.02.021","volume":"84","author":"HS Kazaure","year":"2013","unstructured":"Kazaure HS, Roman SA, Sosa JA. Epidemiology and outcomes of in-hospital cardiopulmonary resuscitation in the United States, 2000\u20132009. Resuscitation. 2013;84(9):1255\u201360.","journal-title":"Resuscitation."},{"issue":"1","key":"161_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/jama.295.1.50","volume":"295","author":"VM Nadkarni","year":"2006","unstructured":"Nadkarni VM, Larkin GL, Peberdy MA, et al. First documented rhythm and clinical outcome from in-hospital cardiac arrest among children and adults. JAMA. 2006;295(1):50\u20137.","journal-title":"JAMA."},{"issue":"5","key":"161_CR50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1742-6723.2008.01126.x","volume":"20","author":"RJ Douglas","year":"2008","unstructured":"Douglas RJ, Cadogan M. Cardiac arrhythmia during propofol sedation. Emerg Med Australas. 2008;20(5):437\u201340.","journal-title":"Emerg Med Australas."},{"issue":"3","key":"161_CR51","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1097\/00000542-200309000-00054","volume":"99","author":"V Rewari","year":"2003","unstructured":"Rewari V, Kaul H. Sustained ventricular tachycardia in long QT syndrome: is propofol the culprit? Anesthesiology. 2003;99(3):764.","journal-title":"Anesthesiology."},{"issue":"5","key":"161_CR52","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/cc8145","volume":"13","author":"RJ Roberts","year":"2009","unstructured":"Roberts RJ, Barletta JF, Fong JJ, et al. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study. Crit Care. 2009;13(5):R169.","journal-title":"Crit Care."},{"issue":"3","key":"161_CR53","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.athoracsur.2011.04.099","volume":"92","author":"C Chrysostomou","year":"2011","unstructured":"Chrysostomou C, Sanchez-de-Toledo J, Wearden P, et al. Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations. Ann Thorac Surg. 2011;92(3):964\u201372.","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"161_CR54","first-page":"781","volume":"38","author":"BA Parent","year":"2010","unstructured":"Parent BA, Munoz R, Shiderly D, Chrysostomou C. Use of dexmedetomidine in sustained ventricular tachycardia. Anaesth Intensive Care. 2010;38(4):781.","journal-title":"Anaesth Intensive Care."},{"issue":"5","key":"161_CR55","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/00000542-199511000-00013","volume":"83","author":"T Kamibayashi","year":"1995","unstructured":"Kamibayashi T, Hayashi Y, Mammoto T, Yamatodani A, Sumikawa K, Yoshiya I. Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane\/epinephrine dysrhythmias in dogs. Anesthesiology. 1995;83(5):992\u20139.","journal-title":"Anesthesiology."},{"issue":"7","key":"161_CR56","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1001\/jama.1970.03180070087018","volume":"214","author":"JS Barrett","year":"1970","unstructured":"Barrett JS, Hey EB Jr. Ventricular arrhythmias associated with the use of diazepam for cardioversion. JAMA. 1970;214(7):1323\u20134.","journal-title":"JAMA."},{"issue":"3","key":"161_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0278-2391(94)90293-3","volume":"52","author":"JA Roelofse","year":"1994","unstructured":"Roelofse JA, van der Bijl P. Cardiac dysrhythmias associated with intravenous lorazepam, diazepam, and midazolam during oral surgery. J Oral Maxillofac Surg. 1994;52(3):247\u201350.","journal-title":"J Oral Maxillofac Surg."},{"issue":"4","key":"161_CR58","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1600-0501.2011.02171.x","volume":"23","author":"MM Romano","year":"2012","unstructured":"Romano MM, Soares MS, Pastore CA, Tornelli MJ, de Oliveira Guare R, Adde CA. A study of effectiveness of midazolam sedation for prevention of myocardial arrhythmias in endosseous implant placement. Clin Oral Implants Res. 2012;23(4):489\u201395.","journal-title":"Clin Oral Implants Res."},{"issue":"5","key":"161_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/clc.4960140507","volume":"14","author":"K Kumagai","year":"1991","unstructured":"Kumagai K, Yamanouchi Y, Matsuo K, Tashiro N, Hiroki T, Arakawa K. Antiarrhythmic and proarrhythmic properties of diazepam demonstrated by electrophysiological study in humans. Clin Cardiol. 1991;14(5):397\u2013401.","journal-title":"Clin Cardiol."},{"issue":"6","key":"161_CR60","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/aps.2011.42","volume":"32","author":"Q Liu","year":"2011","unstructured":"Liu Q, Kong AL, Chen R, et al. Propofol and arrhythmias: two sides of the coin. Acta Pharmacol Sin. 2011;32(6):817\u201323.","journal-title":"Acta Pharmacol Sin."},{"issue":"5","key":"161_CR61","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1213\/ane.0b013e318186499c","volume":"107","author":"C Chrysostomou","year":"2008","unstructured":"Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg. 2008;107(5):1514\u201322.","journal-title":"Anesth Analg."},{"issue":"3","key":"161_CR62","doi-asserted-by":"publisher","first-page":"419","DOI":"10.4103\/0259-1162.123280","volume":"7","author":"K Anand","year":"2013","unstructured":"Anand K, Kumar M. Benzodiazepine overdose associated atrioventricular block. Anesth Essays Res. 2013;7(3):419\u201320.","journal-title":"Anesth Essays Res."},{"issue":"1","key":"161_CR63","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/MJT.0b013e3181dcf572","volume":"19","author":"AM Arroyo Plasencia","year":"2012","unstructured":"Arroyo Plasencia AM, Ballentine LM, Mowry JB, Kao LW. Benzodiazepine-associated atrioventricular block. Am J Ther. 2012;19(1):e48\u201352.","journal-title":"Am J Ther."},{"issue":"1","key":"161_CR64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jclinane.2009.06.002","volume":"22","author":"X Zhang","year":"2010","unstructured":"Zhang X, Schmidt U, Wain JC, Bigatello L. Bradycardia leading to asystole during dexmedetomidine infusion in an 18\u00a0year-old double-lung transplant recipient. J Clin Anesth. 2010;22(1):45\u20139.","journal-title":"J Clin Anesth."},{"issue":"6","key":"161_CR65","first-page":"413","volume":"76","author":"J Huang","year":"2008","unstructured":"Huang J, Wilson S. Severe bradycardia after propofol induction. AANA J. 2008;76(6):413.","journal-title":"AANA J."},{"issue":"9","key":"161_CR66","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1213\/00000539-198809000-00030","volume":"67","author":"P Colson","year":"1988","unstructured":"Colson P, Barlet H, Roquefeuill B, Eledjam JJ. Mechanism of propofol bradycardia. Anesth Analg. 1988;67(9):906\u20137.","journal-title":"Anesth Analg."},{"issue":"4","key":"161_CR67","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4097\/kjae.2013.64.4.363","volume":"64","author":"JI Noh","year":"2013","unstructured":"Noh JI, Lee JH, Woo SY, et al. Complete atrioventricular nodal block after propofol administration in an elderly patient undergoing total knee replacement arthroplasty: a case report. Korean J Anesthesiol. 2013;64(4):363\u20136.","journal-title":"Korean J Anesthesiol."},{"issue":"4","key":"161_CR68","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1213\/00000539-198910000-00019","volume":"69","author":"MF Ganansia","year":"1989","unstructured":"Ganansia MF, Francois TP, Ormezzano X, Pinaud ML, Lepage JY. Atrioventricular Mobitz I block during propofol anesthesia for laparoscopic tubal ligation. Anesth Analg. 1989;69(4):524\u20135.","journal-title":"Anesth Analg."},{"issue":"2","key":"161_CR69","first-page":"130","volume":"17","author":"AR Riera","year":"2010","unstructured":"Riera AR, Uchida AH, Schapachnik E, Dubner S, Filho CF, Ferreira C. Propofol infusion syndrome and Brugada syndrome electrocardiographic phenocopy. Cardiol J. 2010;17(2):130\u20135.","journal-title":"Cardiol J."},{"key":"161_CR70","first-page":"280826","volume":"2013","author":"PP Martorano","year":"2013","unstructured":"Martorano PP, Barboni E, Buscema G, Di Rienzo A. A novel anaesthetical approach to patients with brugada syndrome in neurosurgery. Case Rep Anesthesiol. 2013;2013:280826.","journal-title":"Case Rep Anesthesiol."},{"issue":"4","key":"161_CR71","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40264-014-0150-2","volume":"37","author":"KB Hoffman","year":"2014","unstructured":"Hoffman KB, Dimbil M, Erdman CB, Tatonetti NP, Overstreet BM. The Weber effect and the United States Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010. Drug Saf. 2014;37(4):283\u201394.","journal-title":"Drug Saf."},{"key":"161_CR72","doi-asserted-by":"publisher","first-page":"g1859","DOI":"10.1136\/bmj.g1859","volume":"348","author":"KB Hoffman","year":"2014","unstructured":"Hoffman KB, Demakas A, Erdman CB, Dimbil M. Post-approval adverse events of new and old anticoagulants. BMJ. 2014;348:g1859.","journal-title":"BMJ."},{"issue":"11","key":"161_CR73","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s40264-014-0225-0","volume":"37","author":"KB Hoffman","year":"2014","unstructured":"Hoffman KB, Demakas AR, Dimbil M, Tatonetti NP, Erdman CB. Stimulated reporting: the impact of US Food and Drug Administration-issued alerts on the adverse event reporting system (FAERS). Drug Saf. 2014;37(11):971\u201380.","journal-title":"Drug Saf."},{"issue":"9","key":"161_CR74","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1592\/phco.24.13.1099.38090","volume":"24","author":"A Szarfman","year":"2004","unstructured":"Szarfman A, Tonning JM, Doraiswamy PM. Pharmacovigilance in the 21st century: new systematic tools for an old problem. Pharmacotherapy. 2004;24(9):1099\u2013104.","journal-title":"Pharmacotherapy."},{"key":"161_CR75","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CCM.0b013e3182783b72","volume":"41","author":"J Barr","year":"2013","unstructured":"Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41:263\u2013306.","journal-title":"Crit Care Med"},{"issue":"9","key":"161_CR76","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/CCM.0000000000003259","volume":"46","author":"JW Devlin","year":"2018","unstructured":"Devlin JW, Skrobik Y, Gelinas C, et al. Clinical practice guidelines for the prevention and management of pain, agitation\/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU. Crit Care Med. 2018;46(9):1532\u201348.","journal-title":"Crit Care Med"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-019-00161-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40801-019-00161-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-019-00161-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T21:13:59Z","timestamp":1721596439000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40801-019-00161-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s40801-019-00161-y","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"9 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was supported by departmental funds.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Matthew S. Duprey and John W. Devlin have received support from the National Heart, Lung and Blood Institute (R01HL111111) to help conduct a randomized controlled trial comparing dexmedetomidine and propofol in mechanically ventilated adults. Nada S. Al-Qadheeb, Nick O\u2019Donnell, Keith B. Hoffman, Jonathan Weinstock, Christopher Madias, and Mo Dimbil have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Given the de-identified nature of the FAERS database, this analysis received expedited approval from the Institutional Review Boards at Northeastern University and Tufts Medical Center.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}